Feed/Investors/TOHO-GB Global Life Science Fund

TOHO-GB Global Life Science Fund

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-11-10

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$60M

across 1 round

LATEST ROUND

Series A · $60M · 2026-11-10

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Oyster Therapeutics A pharmaceutical company developing next-generation targeted protein degraders with an initial focus on tau-driven diseases like Alzheimer’s	Series A Verified against 4 of 9 sources	$60M	2026-11-10	[ PART ]